VOLITIONRX LTD — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-05-01

Reporting Person: Butera Salvatore Thomas (CEO-Volition Veterinary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-25	Common Stock	D	15000	—	Disposed	0	Direct
2021-05-01	Common Stock	A	150000	—	Acquired	150000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7000	Direct

Footnotes

F1: The reported transaction involved a cancellation of unvested restricted stock units upon Dr. Butera's resignation as a director of the issuer.

F2: In connection with his employment as Chief Executive Officer of Volition Veterinary Diagnostics Development, LLC, Dr. Butera received restricted stock units subject to a 3-year vesting schedule, vesting as to 50,000 units on each of 05/01/22, 05/01/23 and 05/01/24, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: These shares of Common Stock are jointly owned by Dr. Butera and his spouse.